By using our site you consent to the CTFN Privacy Policy, Cookies Policy, and Terms of Service.
Alere is hoping to erase one major obstacle to its merger with Abbott Laboratories — the uncertainty over its Arriva Medical subsidiary — before an April court date that will determine the
Already a subscriber? Log-in
Ed Roberts began reporting for CTFN in September of 2014. Ed specializes in litigation and regulatory matters. He attended and reported on every major antitrust trial of 2015 and 2016, has covered complex multi-jurisdictional cases such as Fannie Mae/Freddie Mac, and has interviewed senior officials at regulatory bodies such as the FTC. Previously, Ed was a Washington-based reporter covering Congress and Wall Street for a variety of publications for more than two decades. His work has appeared in American Banker, US Banker, National Mortgage News, Payment Source, and the Credit Union Journal, which he co-founded, as well as in numerous daily newspapers. He is a former SEC Bureau Chief for States News Service and is a graduate of Boston University’s School of Public Communication.
Simply fill out the form below and one of our representatives will be in touch.